866-997-4948(US-Canada Toll Free)

Global Conjugate Vaccine Sales Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 119 Pages

Notes:
Sales, means the sales volume of Conjugate Vaccine
Revenue, means the sales value of Conjugate Vaccine

This report studies sales (consumption) of Conjugate Vaccine in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Astellas Pharma Inc
CSL Limited
Emergent BioSolutions
GlaxoSmithKline
Johnson&Johnson
MedImmune
Merck
Pfizer
Sanofi Pasteur
Serum Institute
India Pvt

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Conjugate Vaccine in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Conjugate Vaccine in each application, can be divided into
Application 1
Application 2

Table of Contents

Global Conjugate Vaccine Sales Market Report 2017
1 Conjugate Vaccine Overview
1.1 Product Overview and Scope of Conjugate Vaccine
1.2 Classification of Conjugate Vaccine
1.2.1 Type I
1.2.2 Type II
1.3 Application of Conjugate Vaccine
1.3.1 Application 1
1.3.2 Application 2
1.4 Conjugate Vaccine Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Conjugate Vaccine (2012-2022)
1.5.1 Global Conjugate Vaccine Sales and Growth Rate (2012-2022)
1.5.2 Global Conjugate Vaccine Revenue and Growth Rate (2012-2022)

2 Global Conjugate Vaccine Competition by Manufacturers, Type and Application
2.1 Global Conjugate Vaccine Market Competition by Manufacturers
2.1.1 Global Conjugate Vaccine Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Conjugate Vaccine Revenue and Share by Manufacturers (2012-2017)
2.2 Global Conjugate Vaccine (Volume and Value) by Type
2.2.1 Global Conjugate Vaccine Sales and Market Share by Type (2012-2017)
2.2.2 Global Conjugate Vaccine Revenue and Market Share by Type (2012-2017)
2.3 Global Conjugate Vaccine (Volume and Value) by Regions
2.3.1 Global Conjugate Vaccine Sales and Market Share by Regions (2012-2017)
2.3.2 Global Conjugate Vaccine Revenue and Market Share by Regions (2012-2017)
2.4 Global Conjugate Vaccine (Volume) by Application

3 United States Conjugate Vaccine (Volume, Value and Sales Price)
3.1 United States Conjugate Vaccine Sales and Value (2012-2017)
3.1.1 United States Conjugate Vaccine Sales and Growth Rate (2012-2017)
3.1.2 United States Conjugate Vaccine Revenue and Growth Rate (2012-2017)
3.1.3 United States Conjugate Vaccine Sales Price Trend (2012-2017)
3.2 United States Conjugate Vaccine Sales and Market Share by Manufacturers
3.3 United States Conjugate Vaccine Sales and Market Share by Type
3.4 United States Conjugate Vaccine Sales and Market Share by Application

4 China Conjugate Vaccine (Volume, Value and Sales Price)
4.1 China Conjugate Vaccine Sales and Value (2012-2017)
4.1.1 China Conjugate Vaccine Sales and Growth Rate (2012-2017)
4.1.2 China Conjugate Vaccine Revenue and Growth Rate (2012-2017)
4.1.3 China Conjugate Vaccine Sales Price Trend (2012-2017)
4.2 China Conjugate Vaccine Sales and Market Share by Manufacturers
4.3 China Conjugate Vaccine Sales and Market Share by Type
4.4 China Conjugate Vaccine Sales and Market Share by Application

5 Europe Conjugate Vaccine (Volume, Value and Sales Price)
5.1 Europe Conjugate Vaccine Sales and Value (2012-2017)
5.1.1 Europe Conjugate Vaccine Sales and Growth Rate (2012-2017)
5.1.2 Europe Conjugate Vaccine Revenue and Growth Rate (2012-2017)
5.1.3 Europe Conjugate Vaccine Sales Price Trend (2012-2017)
5.2 Europe Conjugate Vaccine Sales and Market Share by Manufacturers
5.3 Europe Conjugate Vaccine Sales and Market Share by Type
5.4 Europe Conjugate Vaccine Sales and Market Share by Application

6 Japan Conjugate Vaccine (Volume, Value and Sales Price)
6.1 Japan Conjugate Vaccine Sales and Value (2012-2017)
6.1.1 Japan Conjugate Vaccine Sales and Growth Rate (2012-2017)
6.1.2 Japan Conjugate Vaccine Revenue and Growth Rate (2012-2017)
6.1.3 Japan Conjugate Vaccine Sales Price Trend (2012-2017)
6.2 Japan Conjugate Vaccine Sales and Market Share by Manufacturers
6.3 Japan Conjugate Vaccine Sales and Market Share by Type
6.4 Japan Conjugate Vaccine Sales and Market Share by Application
7 Southeast Asia Conjugate Vaccine (Volume, Value and Sales Price)
7.1 Southeast Asia Conjugate Vaccine Sales and Value (2012-2017)
7.1.1 Southeast Asia Conjugate Vaccine Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Conjugate Vaccine Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Conjugate Vaccine Sales Price Trend (2012-2017)
7.2 Southeast Asia Conjugate Vaccine Sales and Market Share by Manufacturers
7.3 Southeast Asia Conjugate Vaccine Sales and Market Share by Type
7.4 Southeast Asia Conjugate Vaccine Sales and Market Share by Application
8 India Conjugate Vaccine (Volume, Value and Sales Price)
8.1 India Conjugate Vaccine Sales and Value (2012-2017)
8.1.1 India Conjugate Vaccine Sales and Growth Rate (2012-2017)
8.1.2 India Conjugate Vaccine Revenue and Growth Rate (2012-2017)
8.1.3 India Conjugate Vaccine Sales Price Trend (2012-2017)
8.2 India Conjugate Vaccine Sales and Market Share by Manufacturers
8.3 India Conjugate Vaccine Sales and Market Share by Type
8.4 India Conjugate Vaccine Sales and Market Share by Application

9 Global Conjugate Vaccine Manufacturers Analysis
9.1 Astellas Pharma Inc
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Conjugate Vaccine Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Astellas Pharma Inc Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 CSL Limited
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Conjugate Vaccine Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 CSL Limited Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Emergent BioSolutions
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Conjugate Vaccine Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Emergent BioSolutions Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 GlaxoSmithKline
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Conjugate Vaccine Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 GlaxoSmithKline Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Johnson&Johnson
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Conjugate Vaccine Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Johnson&Johnson Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 MedImmune
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Conjugate Vaccine Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 MedImmune Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Merck
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Conjugate Vaccine Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Merck Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Pfizer
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Conjugate Vaccine Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Pfizer Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Sanofi Pasteur
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Conjugate Vaccine Product Type, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Sanofi Pasteur Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Serum Institute
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Conjugate Vaccine Product Type, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Serum Institute Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 India Pvt

10 Conjugate Vaccine Maufacturing Cost Analysis
10.1 Conjugate Vaccine Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Conjugate Vaccine
10.3 Manufacturing Process Analysis of Conjugate Vaccine

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Conjugate Vaccine Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Conjugate Vaccine Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Conjugate Vaccine Market Forecast (2017-2022)
14.1 Global Conjugate Vaccine Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Conjugate Vaccine Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Conjugate Vaccine Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Conjugate Vaccine Price and Trend Forecast (2017-2022)
14.2 Global Conjugate Vaccine Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Conjugate Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Conjugate Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Conjugate Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Conjugate Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Conjugate Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Conjugate Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Conjugate Vaccine Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Conjugate Vaccine Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Conjugate Vaccine
Table Classification of Conjugate Vaccine
Figure Global Sales Market Share of Conjugate Vaccine by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Conjugate Vaccine
Figure Global Sales Market Share of Conjugate Vaccine by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Conjugate Vaccine Revenue and Growth Rate (2012-2022)
Figure China Conjugate Vaccine Revenue and Growth Rate (2012-2022)
Figure Europe Conjugate Vaccine Revenue and Growth Rate (2012-2022)
Figure Japan Conjugate Vaccine Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Conjugate Vaccine Revenue and Growth Rate (2012-2022)
Figure India Conjugate Vaccine Revenue and Growth Rate (2012-2022)
Figure Global Conjugate Vaccine Sales and Growth Rate (2012-2022)
Figure Global Conjugate Vaccine Revenue and Growth Rate (2012-2022)
Table Global Conjugate Vaccine Sales of Key Manufacturers (2012-2017)
Table Global Conjugate Vaccine Sales Share by Manufacturers (2012-2017)
Figure 2015 Conjugate Vaccine Sales Share by Manufacturers
Figure 2016 Conjugate Vaccine Sales Share by Manufacturers
Table Global Conjugate Vaccine Revenue by Manufacturers (2012-2017)
Table Global Conjugate Vaccine Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Conjugate Vaccine Revenue Share by Manufacturers
Table 2016 Global Conjugate Vaccine Revenue Share by Manufacturers
Table Global Conjugate Vaccine Sales and Market Share by Type (2012-2017)
Table Global Conjugate Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Conjugate Vaccine by Type (2012-2017)
Figure Global Conjugate Vaccine Sales Growth Rate by Type (2012-2017)
Table Global Conjugate Vaccine Revenue and Market Share by Type (2012-2017)
Table Global Conjugate Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Conjugate Vaccine by Type (2012-2017)
Figure Global Conjugate Vaccine Revenue Growth Rate by Type (2012-2017)
Table Global Conjugate Vaccine Sales and Market Share by Regions (2012-2017)
Table Global Conjugate Vaccine Sales Share by Regions (2012-2017)
Figure Sales Market Share of Conjugate Vaccine by Regions (2012-2017)
Figure Global Conjugate Vaccine Sales Growth Rate by Regions (2012-2017)
Table Global Conjugate Vaccine Revenue and Market Share by Regions (2012-2017)
Table Global Conjugate Vaccine Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Conjugate Vaccine by Regions (2012-2017)
Figure Global Conjugate Vaccine Revenue Growth Rate by Regions (2012-2017)
Table Global Conjugate Vaccine Sales and Market Share by Application (2012-2017)
Table Global Conjugate Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Conjugate Vaccine by Application (2012-2017)
Figure Global Conjugate Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Conjugate Vaccine Sales and Growth Rate (2012-2017)
Figure United States Conjugate Vaccine Revenue and Growth Rate (2012-2017)
Figure United States Conjugate Vaccine Sales Price Trend (2012-2017)
Table United States Conjugate Vaccine Sales by Manufacturers (2012-2017)
Table United States Conjugate Vaccine Market Share by Manufacturers (2012-2017)
Table United States Conjugate Vaccine Sales by Type (2012-2017)
Table United States Conjugate Vaccine Market Share by Type (2012-2017)
Table United States Conjugate Vaccine Sales by Application (2012-2017)
Table United States Conjugate Vaccine Market Share by Application (2012-2017)
Figure China Conjugate Vaccine Sales and Growth Rate (2012-2017)
Figure China Conjugate Vaccine Revenue and Growth Rate (2012-2017)
Figure China Conjugate Vaccine Sales Price Trend (2012-2017)
Table China Conjugate Vaccine Sales by Manufacturers (2012-2017)
Table China Conjugate Vaccine Market Share by Manufacturers (2012-2017)
Table China Conjugate Vaccine Sales by Type (2012-2017)
Table China Conjugate Vaccine Market Share by Type (2012-2017)
Table China Conjugate Vaccine Sales by Application (2012-2017)
Table China Conjugate Vaccine Market Share by Application (2012-2017)
Figure Europe Conjugate Vaccine Sales and Growth Rate (2012-2017)
Figure Europe Conjugate Vaccine Revenue and Growth Rate (2012-2017)
Figure Europe Conjugate Vaccine Sales Price Trend (2012-2017)
Table Europe Conjugate Vaccine Sales by Manufacturers (2012-2017)
Table Europe Conjugate Vaccine Market Share by Manufacturers (2012-2017)
Table Europe Conjugate Vaccine Sales by Type (2012-2017)
Table Europe Conjugate Vaccine Market Share by Type (2012-2017)
Table Europe Conjugate Vaccine Sales by Application (2012-2017)
Table Europe Conjugate Vaccine Market Share by Application (2012-2017)
Figure Japan Conjugate Vaccine Sales and Growth Rate (2012-2017)
Figure Japan Conjugate Vaccine Revenue and Growth Rate (2012-2017)
Figure Japan Conjugate Vaccine Sales Price Trend (2012-2017)
Table Japan Conjugate Vaccine Sales by Manufacturers (2012-2017)
Table Japan Conjugate Vaccine Market Share by Manufacturers (2012-2017)
Table Japan Conjugate Vaccine Sales by Type (2012-2017)
Table Japan Conjugate Vaccine Market Share by Type (2012-2017)
Table Japan Conjugate Vaccine Sales by Application (2012-2017)
Table Japan Conjugate Vaccine Market Share by Application (2012-2017)
Figure Southeast Asia Conjugate Vaccine Sales and Growth Rate (2012-2017)
Figure Southeast Asia Conjugate Vaccine Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Conjugate Vaccine Sales Price Trend (2012-2017)
Table Southeast Asia Conjugate Vaccine Sales by Manufacturers (2012-2017)
Table Southeast Asia Conjugate Vaccine Market Share by Manufacturers (2012-2017)
Table Southeast Asia Conjugate Vaccine Sales by Type (2012-2017)
Table Southeast Asia Conjugate Vaccine Market Share by Type (2012-2017)
Table Southeast Asia Conjugate Vaccine Sales by Application (2012-2017)
Table Southeast Asia Conjugate Vaccine Market Share by Application (2012-2017)
Figure India Conjugate Vaccine Sales and Growth Rate (2012-2017)
Figure India Conjugate Vaccine Revenue and Growth Rate (2012-2017)
Figure India Conjugate Vaccine Sales Price Trend (2012-2017)
Table India Conjugate Vaccine Sales by Manufacturers (2012-2017)
Table India Conjugate Vaccine Market Share by Manufacturers (2012-2017)
Table India Conjugate Vaccine Sales by Type (2012-2017)
Table India Conjugate Vaccine Market Share by Type (2012-2017)
Table India Conjugate Vaccine Sales by Application (2012-2017)
Table India Conjugate Vaccine Market Share by Application (2012-2017)
Table Astellas Pharma Inc Basic Information List
Table Astellas Pharma Inc Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Pharma Inc Conjugate Vaccine Global Market Share (2012-2017)
Table CSL Limited Basic Information List
Table CSL Limited Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CSL Limited Conjugate Vaccine Global Market Share (2012-2017)
Table Emergent BioSolutions Basic Information List
Table Emergent BioSolutions Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Emergent BioSolutions Conjugate Vaccine Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Conjugate Vaccine Global Market Share (2012-2017)
Table Johnson&Johnson Basic Information List
Table Johnson&Johnson Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson&Johnson Conjugate Vaccine Global Market Share (2012-2017)
Table MedImmune Basic Information List
Table MedImmune Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure MedImmune Conjugate Vaccine Global Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Conjugate Vaccine Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Conjugate Vaccine Global Market Share (2012-2017)
Table Sanofi Pasteur Basic Information List
Table Sanofi Pasteur Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Pasteur Conjugate Vaccine Global Market Share (2012-2017)
Table Serum Institute Basic Information List
Table Serum Institute Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Serum Institute Conjugate Vaccine Global Market Share (2012-2017)
Table India Pvt Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Conjugate Vaccine
Figure Manufacturing Process Analysis of Conjugate Vaccine
Figure Conjugate Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Conjugate Vaccine Major Manufacturers in 2015
Table Major Buyers of Conjugate Vaccine
Table Distributors/Traders List
Figure Global Conjugate Vaccine Sales and Growth Rate Forecast (2017-2022)
Figure Global Conjugate Vaccine Revenue and Growth Rate Forecast (2017-2022)
Table Global Conjugate Vaccine Sales Forecast by Regions (2017-2022)
Table Global Conjugate Vaccine Sales Forecast by Type (2017-2022)
Table Global Conjugate Vaccine Sales Forecast by Application (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *